AbbVie Inc. Revenue 2011–2025
AbbVie Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- AbbVie Inc. revenue for the quarter ending March 31, 2026 was 15.0 B, a 12.43% increase year-over-year.
- AbbVie Inc. revenue for the twelve months ending March 31, 2026 was 59.5 B, a 7.95% increase year-over-year.
- AbbVie Inc. annual revenue for 2025 was 61.2 B, a 8.57% increase from 2024.
- AbbVie Inc. annual revenue for 2024 was 56.3 B, a 3.71% increase from 2023.
- AbbVie Inc. annual revenue for 2023 was 54.3 B, a 6.44% decrease from 2022.
- AbbVie Inc. annual revenue for 2022 was 58.1 B.
AbbVie Inc. (ABBV) — Frequently Asked Questions
AbbVie Inc. (ABBV) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $398.84B. In fiscal 2025 it reported revenue of $61.16B and net income of $4.23B. Explore ABBV's stock price, financial statements, earnings history, margins and key ratios below.
What is AbbVie Inc.'s market cap?
AbbVie Inc. (ABBV) has a market capitalization of $398.84B.
What is the ABBV stock price?
ABBV trades at $224.95 (-0.21% on the day).
How much revenue does AbbVie Inc. make?
AbbVie Inc. reported revenue of $61.16B in fiscal 2025.
Is ABBV profitable?
In fiscal 2025, AbbVie Inc. reported net income of $4.23B.
What is ABBV's P/E ratio?
Based on diluted EPS, ABBV has a price-to-earnings (P/E) ratio of about 95.3.